Novonesis (Novozymes) B (NSISBC.XD)
DKK 410.0
(-0.89%)
DKK 410.0
(-0.89%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 9.72 Billion DKK | 1.38% |
| 2022 | 9.59 Billion DKK | 11.02% |
| 2021 | 8.63 Billion DKK | 10.0% |
| 2020 | 7.85 Billion DKK | -1.68% |
| 2019 | 7.98 Billion DKK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.86 Billion DKK | 15.12% |
| 2024 Q2 | 2.86 Billion DKK | -0.01% |
| 2023 Q2 | 2.33 Billion DKK | -6.67% |
| 2023 Q4 | 2.48 Billion DKK | 3.63% |
| 2023 Q1 | 2.5 Billion DKK | 2.75% |
| 2023 FY | 9.72 Billion DKK | 1.38% |
| 2023 Q3 | 2.39 Billion DKK | 2.65% |
| 2022 Q3 | 2.34 Billion DKK | 0.0% |
| 2022 FY | 9.59 Billion DKK | 11.02% |
| 2022 Q4 | 2.43 Billion DKK | 3.75% |
| 2021 FY | 8.63 Billion DKK | 10.0% |
| 2020 FY | 7.85 Billion DKK | -1.68% |
| 2019 FY | 7.98 Billion DKK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|